Dual RAAS inhibitor therapy tied to increased risk of acute kidney injury in diabetic kidney disease patients Dr. Kamal Kant Kohli3 Aug 2023 8:00 PM ISTCanada: A recent review published in Nephrology Dialysis Transplantation found an increased risk of hyperkalemia and acute kidney injury (AKI) with...
Patiromer use lower hyperkalemia risk in HFrEF patients: DIAMOND trial Medha Baranwal5 Aug 2022 8:00 PM ISTUSA: Simultaneous use of patiromer and high-dose mineralocorticoid receptor antagonist (MRA) lowers the risk of recurrent hyperkalemia in patients...
Managing heart failure with sacubitril-valsartan: Why ARNIs stand out? dr. Abhimanyu Uppal30 July 2022 11:18 AM ISTHeart failure (HF) is a major economic and health burden worldwide, characterized by the presence of dyspnea or limited exertion due to impaired...
Anti Hypertensives reducing the Aneurysm Rupture risk Isra Zaman6 Jun 2022 9:00 AM ISTA multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood...
Beta-blockers and RAAS inhibitors may prevent LVEF dysfunction due to breast cancer drugs: Study Medha Baranwal24 Jan 2022 11:00 AM ISTSweden: A meta-analysis suggests that beta-blockers (BBs) and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBs) may...
RAASis discontinuation causes recurrent hyperkalemia and hospitalization: Study MD Editorial Team22 Nov 2021 9:00 AM ISTFrance: A new study by Patrick Rossignol and the team revealed that recurrent hyperkalemia (HK) is associated with RAASi discontinuation and dose...
Hyperkalemia due to RAASi best managed by stopping the drugs MD Bureau10 Sept 2021 9:00 AM ISTRenin-Angiotensin-Aldosterone System Inhibitors (RAASi) may precipitate hyperkalemia which is best managed by discontinuing the drugs, according to a...
Renin-angiotensin-system inhibitors in COVID-19:To be continued or not? Dr Sravan Kumar16 Aug 2021 9:00 AM IST SARS-CoV-2 enters human cells through angiotensin-converting enzyme 2 (ACE2), which plays an important role in the renin–angiotensin system. The...
Hyperkalemia due to RAASi is best managed by stopping the drugs MD Bureau7 July 2021 9:00 AM ISTRAAS Inhibitor Discontinuation Lowers Risk of Recurrent Hyperkalemia Due to the Drugs, reveals a new Study
Mortality rates lowered in aortic dissection with beta-blockers and RAAS inhibitors; JAMA Dr Satabdi Saha16 March 2021 10:00 AM ISTAccording to a recent research report, the use of beta-blockers, ACEIs, or ARBs was associated with benefits in the long-term treatment of aortic...
